ArticleCureus2025
Paracentral Acute Middle Maculopathy in a Young-Onset Case Revealing Undiagnosed Hypertension.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paracentral acute middle maculopathy (PAMM) is a rare retinal ischemic disorder resulting from ischemia of the intermediate and deep retinal capillary plexus (DCP), causing secondary injury to the inner nuclear layer (INL). It typically occurs in older adults with vascular risk factors but can rarely present in young patients without prior systemic disease. A 37-year-old man presented with sudden visual impairment in the right eye. Fundus photography and fluorescein angiography were unremarkable; however, Humphrey visual field testing revealed a paracentral scotoma. Optical coherence tomography (OCT) revealed a band-like hyperreflective lesion in the INL, and OCT angiography (OCTA) revealed a localized DCP dropout. Systemic evaluation identified previously undiagnosed hypertension (213/136 mmHg), and laboratory tests excluded diabetes, dyslipidemia, and hypercoagulable disorders. Therefore, oral antihypertensive therapy was initiated. Three months later, blood pressure normalized (127/86 mmHg), the intensity and thickness of the OCT lesion decreased, and visual symptoms improved, although DCP dropout persisted on OCTA. This case demonstrates that young-onset PAMM may be the first sign of systemic hypertension. Elevated blood pressure can induce retinal microvascular ischemia, and timely management can lead to partial functional recovery despite persistent structural changes. Comprehensive systemic evaluation is recommended in young patients with PAMM to prevent further ischemic damage and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.